Clinical Trial: Study on the impact of rapid nucleic acid detection technology based on PCR-fluorescent probe method on the diagnosis and treatment of pulmonary tuberculosis. (China)

Posted On: 2026-08-21

China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the impact of rapid nucleic acid detection technology based on PCR-fluorescent probe method on the diagnosis and treatment of pulmonary tuberculosis.'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130528

Registration Time: 2026/08/20

Type: Diagnostic test

Primary Sponsor: Hainan Medical College First Affiliated Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338876

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Study on the impact of rapid nucleic acid detection technology based on PCR-fluorescent probe method on the diagnosis and treatment of pulmonary tuberculosis. (China)